Relmada Therapeutics, Inc. · NASDAQ:RLMD
Janus Henderson Group PLC reported a 10.10% stake in Relmada Therapeutics, Inc. (Schedule 13G)
Event Jan 30, 2026 · Filed Feb 6, 2026
Janus Henderson Group PLC reported a 10.10% stake in Relmada Therapeutics, Inc., 7,439,415 shares, as a passive investor on Jan 30, 2026. Filed Feb 6, 2026 (Schedule 13G).
- Stake
- 10.10%
- Shares
- 7,439,415
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 10.10% | 7,439,415 |
Source
Related
- Relmada Therapeutics, Inc.
- Janus Henderson Group PLC
- Relmada Therapeutics, Inc. shareholders
- Form 4 · Shenouda Maged · Sep 11, 2026
- Form 4 · Traversa Sergio · Sep 11, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · Millennium Management LLC · Jun 22, 2026